Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent
US8252753B2 · kind B2 · utility
1Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 2004 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | Dec 28, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to oligonucleotide sequences and their derivatives.These oligonucleotide sequences are capable of hybridising with the genes or with products of the genes coding for the PKC-beta 1.This invention also relates to the use of these oligonucleotide sequences as a depigmenting or bleaching agent for the skin in a cosmetic composition or in a topical pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.